These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12649411)

  • 41. Clinical and radiographic results from a 2-year comparison of once-weekly versus twice-weekly administration of etanercept in biologics-naive patients with rheumatoid arthritis.
    Wada T; Son Y; Ozaki Y; Nomura S; Iida H
    Mod Rheumatol; 2012 Nov; 22(6):824-30. PubMed ID: 22302136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the efficacy and safety of etanercept 50 mg once weekly in Japanese patients with rheumatoid arthritis and comparison with 25 mg etanercept twice weekly.
    Mochizuki T; Momohara S; Yano K; Shirahata T; Ikari K
    Mod Rheumatol; 2013 Sep; 23(5):994-1000. PubMed ID: 23138447
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Etanercept and methotrexate in rheumatoid arthritis.
    Malgarini RB; Pimpinella G
    Lancet; 2004 May; 363(9422):1733; author reply 1733. PubMed ID: 15158641
    [No Abstract]   [Full Text] [Related]  

  • 44. Imaging progression despite clinical remission in early rheumatoid arthritis patients after etanercept interruption.
    Laganà B; Picchianti Diamanti A; Ferlito C; Germano V; Migliore A; Cremona A; Argento G; David V; Salemi S; D'Amelio R
    Int J Immunopathol Pharmacol; 2009; 22(2):447-54. PubMed ID: 19505397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of moderate rheumatoid arthritis with different strategies in a health resource-limited setting: a cost-effectiveness analysis in the era of biosimilars.
    Wu B; Song Y; Leng L; Bucala R; Lu LJ
    Clin Exp Rheumatol; 2015; 33(1):20-6. PubMed ID: 25438197
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2).
    Gibofsky A; Cannon GW; Harrison DJ; Joseph GJ; Bitman B; Chaudhari S; Collier DH
    Clin Exp Rheumatol; 2015; 33(3):297-301. PubMed ID: 25738333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
    Bliddal H; Terslev L; Qvistgaard E; Konig M; Holm CC; Rogind H; Boesen M; Danneskiold-Samsøe B; Torp-Pedersen S
    Scand J Rheumatol; 2006; 35(5):341-5. PubMed ID: 17062431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis.
    Koens L; Senff NJ; Vermeer MH; Ronday HK; Willemze R; Jansen PM
    Acta Derm Venereol; 2009 Nov; 89(6):653-4. PubMed ID: 19997706
    [No Abstract]   [Full Text] [Related]  

  • 49. Etanercept response in patients with rheumatoid arthritis after secondary loss of efficacy of infliximab.
    Matsuno H
    Mod Rheumatol; 2010 Dec; 20(6):561-5. PubMed ID: 20552246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Etanercept].
    Mühlhäuser U; Münzel F; Eschenhagen T
    Dtsch Med Wochenschr; 2003 Aug; 128(34-35):1775-8. PubMed ID: 12934172
    [No Abstract]   [Full Text] [Related]  

  • 51. Utilization and adherence patterns of subcutaneously administered anti-tumor necrosis factor treatment among rheumatoid arthritis patients.
    Tkacz J; Ellis L; Bolge SC; Meyer R; Brady BL; Ruetsch C
    Clin Ther; 2014 May; 36(5):737-47. PubMed ID: 24661783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of triple therapy versus etanercept plus methotrexate in rheumatoid arthritis: comment on the article by Moreland et al.
    Graudal N; Jürgens G
    Arthritis Rheum; 2013 Feb; 65(2):539. PubMed ID: 23125025
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluation of etanercept dose reduction in patients with rheumatoid arthritis using pharmacokinetic/pharmacodynamic modeling and simulation.
    Hsu LF; Huang JD
    Int J Clin Pharmacol Ther; 2014 Sep; 52(9):776-86. PubMed ID: 24887337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Educational session as a tool to increase patient satisfaction of switching etanercept from the prefilled syringe to the autoinjection pen.
    Borrás-Blasco J; Gracia-Pérez A; Casterá MD; Rosique-Robles JD; Abad J
    Expert Opin Biol Ther; 2013 Aug; 13(8):1103-8. PubMed ID: 23675687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.
    van der Heijde D; Klareskog L; Rodriguez-Valverde V; Codreanu C; Bolosiu H; Melo-Gomes J; Tornero-Molina J; Wajdula J; Pedersen R; Fatenejad S;
    Arthritis Rheum; 2006 Apr; 54(4):1063-74. PubMed ID: 16572441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reply: The effect of triple therapy versus etanercept plus methotrexate in rheumatoid arthritis: comment on the article by Moreland et al.
    Moreland LW
    Arthritis Rheum; 2013 Feb; 65(2):539-40. PubMed ID: 23124989
    [No Abstract]   [Full Text] [Related]  

  • 57. The miracle of motion: two new drugs target not just the horrific pain of rheumatoid arthritis, but the disease itself.
    Kalb C
    Newsweek; 1999 Oct; 134(14):63. PubMed ID: 10620974
    [No Abstract]   [Full Text] [Related]  

  • 58. Two RA drugs better than one.
    Health News; 2004 May; 10(5):10. PubMed ID: 15132111
    [No Abstract]   [Full Text] [Related]  

  • 59. Etanercept compared to intraarticular corticosteroid injection in rheumatoid arthritis: double-blind, randomized pilot study.
    Roux CH; Breuil V; Valerio L; Amoretti N; Brocq O; Albert C; Grisot C; Allam Y; Chevalier P; Pradier C; Euller-Ziegler L
    J Rheumatol; 2011 Jun; 38(6):1009-11. PubMed ID: 21406499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Keystone EC; Schiff MH; Kremer JM; Kafka S; Lovy M; DeVries T; Burge DJ
    Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.